Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| 1 |
GE Vernova
GEV
|
$447M |
| 2 |
Bristol-Myers Squibb
BMY
|
$365M |
| 3 |
SW
Smurfit Westrock plc
SW
|
$361M |
| 4 |
Visa
V
|
$347M |
| 5 |
Omnicom Group
OMC
|
$336M |
Top Sells
| 1 |
Vanguard S&P 500 ETF
VOO
|
$1.34B |
| 2 |
Microsoft
MSFT
|
$1.04B |
| 3 |
NVIDIA
NVDA
|
$928M |
| 4 |
Apple
AAPL
|
$637M |
| 5 |
Eli Lilly
LLY
|
$534M |
Sector Composition
| 1 | Technology | 27.41% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.84% |
| 4 | Consumer Discretionary | 9.52% |
| 5 | Industrials | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Hyperfine
HYPR
$91.9M
| $185K | ﹤0.01% |
171,495
| – | – |
|
3802
Anixa Biosciences
ANIX
$95.7M
| $185K | ﹤0.01% |
58,745
-14,305
| -20% | -$45.1K |
|
3803
Empire Petroleum
EP
$168M
| $185K | ﹤0.01% |
35,225
-9,767
| -22% | -$51.3K |
|
3804
NL Industries
NL
$311M
| $185K | ﹤0.01% |
24,844
-6,651
| -21% | -$49.4K |
|
3805
Flotek Industries
FTK
$336M
| $185K | ﹤0.01% |
37,049
| – | – |
|
3806
Invivyd
IVVD
$239M
| $184K | ﹤0.01% |
180,758
-58,615
| -24% | -$59.8K |
|
3807
RAPT Therapeutics
RAPT
$214M
| $181K | ﹤0.01% |
11,276
-3,048
| -21% | -$49K |
|
3808
Century Therapeutics
IPSC
$43.6M
| $181K | ﹤0.01% |
105,994
-43,006
| -29% | -$73.5K |
|
3809
Skye Bioscience
SKYE
$124M
| $176K | ﹤0.01% |
44,907
-13,871
| -24% | -$54.2K |
|
3810
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.74B
| $174K | ﹤0.01% |
+20,002
| New | +$174K |
|
3811
908 Devices
MASS
$196M
| $173K | ﹤0.01% |
49,930
-19,620
| -28% | -$68.1K |
|
3812
BlackRock Resources & Commodities Strategy Trust
BCX
$784M
| $173K | ﹤0.01% |
+18,003
| New | +$173K |
|
3813
OP Bancorp
OPBK
$212M
| $172K | ﹤0.01% |
13,781
-1
| -0% | -$12 |
|
3814
Co-Diagnostics
CODX
$11.9M
| $171K | ﹤0.01% |
137,068
| – | – |
|
3815
Neuropace
NPCE
$322M
| $169K | ﹤0.01% |
24,209
-9,850
| -29% | -$68.7K |
|
3816
Rekor Systems
REKR
$138M
| $167K | ﹤0.01% |
141,882
-48,848
| -26% | -$57.6K |
|
3817
Aemetis
AMTX
$151M
| $163K | ﹤0.01% |
70,919
-30,884
| -30% | -$71K |
|
3818
IAMGOLD
IAG
$5.7B
| $163K | ﹤0.01% |
31,085
-7,793
| -20% | -$40.8K |
|
3819
Key Tronic
KTCC
$34.2M
| $162K | ﹤0.01% |
28,237
| – | – |
|
3820
Greenwich LifeSciences
GLSI
$149M
| $161K | ﹤0.01% |
11,203
-4,092
| -27% | -$58.8K |
|
|
GATO
3821
DELISTED
Gatos Silver, Inc.
GATO
| $159K | ﹤0.01% |
+10,531
| New | +$159K |
|
3822
Gyre Therapeutics
GYRE
$698M
| $157K | ﹤0.01% |
12,507
-5,759
| -32% | -$72.2K |
|
3823
FibroBiologics
FBLG
$24.1M
| $156K | ﹤0.01% |
50,399
-18,159
| -26% | -$56.1K |
|
3824
Nuveen Floating Rate Income Fund
JFR
$1.13B
| $155K | ﹤0.01% |
17,591
+3,743
| +27% | +$33K |
|
|
RDNW
3825
RideNow Group, Inc. Class B Common Stock
RDNW
$150M
| $155K | ﹤0.01% |
32,296
-12,072
| -27% | -$57.8K |
|